Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04314596 · ClinicalTrials.gov registry record · NA

The Effects of Antioxidant Supplementation on Multiple Endurance Race Performance, Physiology, and Recovery.

A NA study, sponsored by Applied Science & Performance Institute.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT04314596 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04314596, a NA study, has completed, sponsored by Applied Science & Performance Institute.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Thirty active male and female athletes will be recruited for the study. Subjects will be examined at baseline for VO2max performance. Subjects will then be stratified and randomly divided equally (50% - 50%) into an Oceanix (supplemental) or placebo condition such that baseline VO2max match. Once randomization, subjects will be baseline tested for multiple measures of muscle force capacity, muscle soreness, immune function, and endocrine function. Upon completion of baseline testing, subjects will all complete a one-day, cross-training course in Tampa, Florida. The training course is known to be extremely vigorous and causes significant muscle damage. Subjects will then be retested for muscle function at 24, and 48 hours following the course. At 24- and 48-hours subjects will be asked to repeat a simulated time trial race. In this way, we will measure repeated race performance, recovery from intense exercise, muscle damage from exercise, and immune function during multiple races.

Interventions

  • DIETARY_SUPPLEMENT Oceanix
  • OTHER Cross Training Course

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-01-20
Est. Completion 2020-02-19
Phase NA

What the Registry Record Tells You About NCT04314596

The ClinicalTrials.gov registry entry for NCT04314596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Oceanix is the first listed.

NCT04314596 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04314596 about?

NCT04314596 is a clinical study titled "The Effects of Antioxidant Supplementation on Multiple Endurance Race Performance, Physiology, and Recovery.". Thirty active male and female athletes will be recruited for the study. Subjects will be examined at baseline for VO2max performance. Subjects will then be stratified and randomly divided equally (50% - 50%) into an Oceanix (supplemental) or placebo condition such that baseline VO2max match. Once ra...

What is the current status of trial NCT04314596?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-01-20. Estimated completion is 2020-02-19.

What interventions are being tested in trial NCT04314596?

The interventions under investigation include: Oceanix (DIETARY_SUPPLEMENT), Cross Training Course (OTHER).

Who is sponsoring clinical trial NCT04314596?

This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.